75 related articles for article (PubMed ID: 16565234)
1. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
[TBL] [Abstract][Full Text] [Related]
2. Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria's given by WHO, NCEPATP III and IDF.
Lone S; Lone K; Khan S; Pampori RA
J Epidemiol Glob Health; 2017 Dec; 7(4):235-239. PubMed ID: 29110863
[TBL] [Abstract][Full Text] [Related]
3. Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet.
Santamarina AB; Oliveira JL; Silva FP; Carnier J; Mennitti LV; Santana AA; de Souza GH; Ribeiro EB; Oller do Nascimento CM; Lira FS; Oyama LM
PLoS One; 2015; 10(11):e0141227. PubMed ID: 26536464
[TBL] [Abstract][Full Text] [Related]
4. Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women's Health Initiative.
Sorensen MD; Chi T; Shara NM; Wang H; Hsi RS; Orchard T; Kahn AJ; Jackson RD; Miller J; Reiner AP; Stoller ML
J Am Soc Nephrol; 2014 Feb; 25(2):362-9. PubMed ID: 24335976
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome in hypertension: European society of hypertension position statement.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive therapy in patients with metabolic syndrome.
Segura J; Ruilope LM
Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):493-7. PubMed ID: 16914961
[TBL] [Abstract][Full Text] [Related]
7. The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.
Ruilope L; Kjeldsen SE; de la Sierra A; Mancia G; Ruggenenti P; Stergiou GS; Bakris GL; Giles TD
Blood Press; 2007; 16(2):72-9. PubMed ID: 17612904
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and cardiovascular risk in primary hypertension.
Ratto E; Leoncini G; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S120-2. PubMed ID: 16565234
[TBL] [Abstract][Full Text] [Related]
9. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome.
Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
